Canton Strategic Holdings (CNTN) Enterprise Value (2022 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Enterprise Value came in at -$41.5 million in Q1 2026, down 3760.12% YoY from $1.1 million in Q1 2025, and down 143.84% on a QoQ basis from -$17.0 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Enterprise Value (2022 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 7 years of Enterprise Value data on file, last reported at -$41.5 million in Q1 2026.
- Quarterly Enterprise Value fell 3760.12% year-over-year to -$41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.5 million (down 3760.12% YoY) and the FY2025 annual result came in at -$17.0 million, down 378.53% from the prior year.
- Enterprise Value eased to -$41.5 million in Q1 2026, from -$17.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q1 2025 to a low of -$41.5 million in Q1 2026.
- A 5-year average of -$8.8 million and a median of -$7.6 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 149361.29% — and 2025, when it soared 87.23%.
- Tracing CNTN's Enterprise Value over 5 years: stood at -$6.5 million in 2022, then tumbled by 67.96% to -$10.9 million in 2023, then soared by 67.45% to -$3.6 million in 2024, then tumbled by 378.53% to -$17.0 million in 2025, then plunged by 143.84% to -$41.5 million in 2026.
- The last three Enterprise Value figures came in at -$41.5 million (Q1 2026), -$17.0 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 574.32 Mn |
| Mar 31, 2026 | 637.67 Mn |
| Dec 31, 2025 | 100.44 Mn |
| Sep 30, 2025 | 12.86 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | -927,892.34 |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -4.03 Mn |
| Mar 31, 2024 | 67.62 Mn |
| Dec 31, 2023 | -961,813.49 |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 2.30 Bn |
| Mar 31, 2023 | 3.42 Bn |
| Dec 31, 2022 | 1.68 Bn |
| Sep 30, 2022 | 3.49 Bn |
| Jun 30, 2022 | 3.38 Bn |
| Mar 31, 2022 | 6.81 Bn |